Improved hemostasis with major hepatic resection in the current surgical era
- PMID: 31307940
- DOI: 10.1016/j.hbpd.2019.07.002
Improved hemostasis with major hepatic resection in the current surgical era
Abstract
Background: Major hepatic resection, predominantly performed for oncologic intent, is a complex procedure with the potential for severe intraoperative hemorrhage. The current surgical era has the ability to improve hemostasis throughout the performance of major hepatic resections which decreases blood transfusions and the detrimental effects associated with transfusion. We evaluated hemostasis and outcomes in the current surgical era of performing hepatic resections.
Methods: Utilizing the American College of Surgeons (ACS) National Surgical Quality Improvement Program (NSQIP) database all major hepatic resections performed between 2012 and 2016 were analyzed in regards to hemostasis. Hemostasis was evaluated by the need for and magnitude of blood transfusions. Additional perioperative variables (including operative time, length of hospital stay, and mortality rates) were analyzed to assess for outcomes with hemostasis. The NSQIP results were compared to previous publications involving major hepatic resections to detect improvement in hemostasis and outcomes in the current surgical era.
Results: A total of 22777 major hepatic resections met the inclusion criteria for analysis in the NSQIP database. An additional 21198 cases were compiled within the selected publications for comparative analysis. The transfusion rate in the current surgical era was 13.3% versus 38.7% in the previous era (P = 0.0001). When a transfusion was required in the current surgical era there was a two-fold reduction in the number of units transfused (1.5 U vs. 3.8 U, P = 0.0001). Statistically significant improvements in operative time and length of hospital stay were presented within the current surgical era (P = 0.0001). When a transfusion was required there was an increased relative risk score of 7 for mortality (4.9% vs. 0.7%, P = 0.0001), however, improvement in mortality rates did not reach statistical significance across surgical eras (1.3% vs. 4.0%, P = 0.0001).
Conclusions: The conduction of major hepatic resection in the current surgical era is more hemostatic. Correlated with improved hemostasis are better outcomes for both clinical and financial endpoints. These findings should encourage continued and increased performance of major hepatic resections.
Keywords: Improved hemostasis; Improved outcomes; Major hepatic resection.
Copyright © 2019 First Affiliated Hospital, Zhejiang University School of Medicine in China. Published by Elsevier B.V. All rights reserved.
Similar articles
-
Advances in hepatectomy technique: Toward zero transfusions in the modern era of liver surgery.Surgery. 2016 Mar;159(3):793-801. doi: 10.1016/j.surg.2015.10.006. Epub 2015 Nov 14. Surgery. 2016. PMID: 26584854
-
Trends in morbidity and mortality of hepatic resection for malignancy. A matched comparative analysis.Ann Surg. 1994 Aug;220(2):199-205. doi: 10.1097/00000658-199408000-00012. Ann Surg. 1994. PMID: 8053742 Free PMC article.
-
Outcomes of central hepatectomy versus extended hepatectomy.Hepatobiliary Pancreat Dis Int. 2019 Jun;18(3):249-254. doi: 10.1016/j.hbpd.2019.03.005. Epub 2019 Mar 26. Hepatobiliary Pancreat Dis Int. 2019. PMID: 30987899
-
Hepatic resections: changing mortality and morbidity.Am Surg. 1994 Oct;60(10):748-52. Am Surg. 1994. PMID: 7944036 Review.
-
Hemostasis and Hepatic Surgery.Surg Clin North Am. 2016 Apr;96(2):219-28. doi: 10.1016/j.suc.2015.12.001. Epub 2016 Feb 17. Surg Clin North Am. 2016. PMID: 27017861 Review.
Cited by
-
Risk factors and outcomes for cholangitis after hepatic resection.Langenbecks Arch Surg. 2023 Jun 17;408(1):236. doi: 10.1007/s00423-023-02769-9. Langenbecks Arch Surg. 2023. PMID: 37329363
-
A Comparative Study of an Integrated Ultrasonic/Bipolar Sealing Device Versus an Articulating Bipolar Sealing Device for Laparoscopic Liver Surgery.World J Surg. 2022 Dec;46(12):2963-2972. doi: 10.1007/s00268-022-06734-3. Epub 2022 Sep 21. World J Surg. 2022. PMID: 36131184
-
Stage-by-stage analysis of the effect of blood transfusion on survival after curative hepatectomy for hepatocellular carcinoma-a retrospective study.Langenbecks Arch Surg. 2024 Mar 4;409(1):83. doi: 10.1007/s00423-024-03278-z. Langenbecks Arch Surg. 2024. PMID: 38436871
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous